Medicine and Dentistry
Antiretroviral Therapy
9%
Atypical Mycobacterium
6%
C Reactive Protein
5%
Cellular Immunity
7%
Cohort Analysis
37%
Cohort Effect
6%
Comorbidity
7%
COVID-19
27%
Cross Sectional Study
11%
Diagnosis
16%
Diagnostic Accuracy
15%
Disease
13%
Emergency Department
7%
Hazard Ratio
5%
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus Infection
5%
Infection
37%
Kidney Graft
5%
Lipoarabinomannan
14%
Logistic Regression Analysis
6%
Lung
5%
Lung Tuberculosis
6%
Messenger RNA
8%
Meta-Analysis
8%
Multiple Sclerosis
5%
Mycobacterium Tuberculosis
6%
Mycobacterium Tuberculosis Complex
5%
Odds Ratio
10%
Outpatient
8%
Population
10%
Prevalence
19%
Prospective Cohort Study
5%
Randomized Controlled Trial
5%
Retrospective Study
5%
Severe Acute Respiratory Syndrome Coronavirus 2
37%
Systematic Review
7%
Tuberculosis Treatment
6%
Tuberculous Meningitis
8%
Urinary Tract Infection
5%
Wart Virus
6%
Pharmacology, Toxicology and Pharmaceutical Science
Antivirus Agent
5%
Atypical Mycobacterium
7%
C Reactive Protein
8%
Cohort Study
28%
Common Variable Immunodeficiency
5%
Comorbidity
7%
Coronavirinae
11%
COVID-19 Vaccine
7%
Cross-Sectional Study
5%
Dexamethasone
5%
Disease
21%
Drug Resistance
5%
Drug Resistant Tuberculosis
5%
HIV
46%
Immunogenicity
6%
Infection
29%
Isoniazid
6%
Lipoarabinomannan
8%
Lung Tuberculosis
5%
Messenger RNA
7%
Monoclonal Antibody
6%
mRNA Vaccine
5%
Mycobacterium Tuberculosis
5%
Placebo
11%
Prevalence
20%
Prospective Cohort Study
7%
Randomized Controlled Trial
7%
Remdesivir
5%
Retrospective Study
5%
SARS Coronavirus
33%
Tuberculostatic Agent
8%
Tuberculous Meningitis
8%
Immunology and Microbiology
Adoptive Immunity
8%
Antibody Response
12%
Blood Plasma
5%
Breakthrough Infection
11%
Common Variable Immunodeficiency
5%
Comorbidity
6%
COVID-19
17%
Familial Mediterranean Fever
5%
Human Immunodeficiency Virus
28%
Human Immunodeficiency Virus 1
5%
Humoral Immunity
6%
Immune Response
6%
Immunology
25%
Multiple Sclerosis
5%
Mycobacterium Tuberculosis
5%
Mycobacterium Tuberculosis Complex
6%
Nontuberculous mycobacteria
8%
Omicron Coronavirus Variant
10%
Prevalence
11%
Severe Acute Respiratory Syndrome Coronavirus 2
49%
Spike
14%
Tuberculous Meningitis
5%
